Kailan Pharma Closes Oversubscribed A+ Round of Over 100 Million RMB to Advance Cholesterol Metabolism Drug R&D
Striving to provide alternative treatment options for patients with metabolic diseases.
@gaorong
创造美好生活
Striving to provide alternative treatment options for patients with metabolic diseases.
From AI-assisted investment research to AI-assisted investment decision-making.
Where lofty peaks and flowing waters find their joy, The banyan-shaded spring shares this same spring.
Digitalization and AI are driving intelligent decision-making and granular management across supply chains.
Accelerating on the "fast track" of TRT therapy.
Surgery with peace of mind, lives lived to their fullest.
Continue deepening the "all demographics, all price points, global reach" strategy.
Innovation as the sail, hard work as the oar.
Gaorong Ventures wishes you a Happy New Year 2025!
"When you meet a mountain, you cut a path through it; when you meet a river, you build a bridge across it."